Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance

Autoria(s): Boon, James; Hoy, Andrew J.; Stark, Romana; Brown, Russell D.; Meex, Ruth C.; Henstridge, Darren C.; Schenk, Simon; Meikle, Peter J.; Horowitz, Jeffrey F.; Kingwell, Bronwyn A.; Bruce, Clinton R.; Watt, Matthew J.
Data(s)

01/02/2013
Identificador

http://hdl.handle.net/10536/DRO/DU:30062071
Idioma(s)

eng
Publicador

American Diabetes Association
Relação

http://dro.deakin.edu.au/eserv/DU:30062071/bruce-ceramidescontained-2013.pdf

http://doi.org/10.2337/db12-0686
Palavras-Chave #dysregulated lipid metabolism #inflammation #insulin resistance #obesity #sphingolipid ceramide #LDL #type 2 diabetes #skeletal muscle
Tipo

Journal Article
Acesso ao item digital